Novasenta
PrivateLast Round
Series B
Feb 5, 2024
Est. Valuation
$78M
Total Funding Raised
$75M
Company Overview
Novasenta is a biotechnology company that develops innovative immuno-oncology therapeutics and utilizes a machine-learning platform to discover potential drug targets within the tumor microenvironment, aiming to provide safer and more effective cancer treatments.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Novasenta Comparables
Compare Novasenta with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Coherus BioSciences Inc | 81% | |
| Asher Biotherapeutics | 79% | |
| NextCure Inc | 76% | |
Novasenta Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Feb 5, 2024 | ||||
| Series A | Jul 29, 2022 | ||||
| Seed | Aug 23, 2021 |
Novasenta Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| UPMC | Series A |
| UPMC Enterprises | Seed, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 5, 2024
$15M round closed.
- Jul 29, 2022
$40M round led by UPMC Enterprises
Novasenta Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Novasenta's valuation, stock price, and market status.